Dissecting the Molecular Mechanism of Intraflagellar Transport Motors

Lead Research Organisation: Birkbeck, University of London
Department Name: Biological Sciences

Abstract

The 30 trillion cells that make up the human body fall into ~200 major types. Virtually all of these cell types grow an antenna-like structure called the cilium, which projects from the cell surface into the environment. Distantly related organisms such as protozoa and green algae also possess cilia, suggesting that they are ancient organelles that pre-date the last common ancestor of all eukaryotes. Cilia serve vital sensory roles, detecting and processing environmental stimuli such as light, olfactants, morphogens and fluid flow. A subset of cilia actively beat with a wave-like motion to generate cell propulsion, for example in sperm cells, or movement of fluid over the epithelia lining the airways and oviduct. Defects in the architecture and composition of cilia cause a plethora of disorders collectively known as ciliopathies. Hence, deciphering the mechanisms by which cilia are assembled and function is fundamental to understanding a wide array of biological processes and the molecular basis of disease states. We are particularly interested in the central mechanism underpinning cilia formation and function. This constitutes a transport system that moves building blocks from the cytoplasm to the tip the cilium and returns products to the cell body. It is powered by two types of ATP-fueled motor protein, which move in opposite directions along the cilium. We wish to uncover the unique mechanisms through which the motor proteins generate force and movement, coordinate round trips of transportation, and avoid colliding with each other as they traverse the cilium. To achieve this, we will use new tools to produce and manipulate the motors for detailed study.

Technical Summary

We seek to gain insight into the molecular mechanism of intraflagellar transport (IFT), the motor-protein driven process essential for the construction and maintenance of cilia. We will focus on the microtubule-based motors Kif3, which moves building blocks and functional components from the cell body to the tip of the cilium, and dynein-2, which powers transport in the opposite direction. A striking feature of IFT is that Kif3 and dynein-2 operate in long linear arrays containing multiple copies of both motors, but how these multi-megadalton motor assemblies coordinate IFT is not well understood. In Aim 1, we will exploit our newly developed recombinant expression systems for human Kif3 and dynein-2 to determine their motile behaviour and force production at the single molecule level, and probe their regulation using site directed mutagenesis. In Aim 2 we will systematically explore the impact and functional consequences of multiple motors in IFT, developing tools to link together Kif3 and dynein-2 with exquisite control over the number, position, and type of motor per assembly. In Aim 3, we will discover if Kif3 and dynein-2 use post-translational modifications on their microtubule tracks in order to avoid colliding with one another as they move in opposite directions along the cilium. Such ciliary kinesin and dynein navigation using post-translational modifications would represent a landmark result in the 'tubulin code'. Overall, this combination of biochemical, biophysical and synthetic biology approaches will shed new light on motor protein mechanisms and the assembly and maintenance of cilia, while developing new biotechnological tools that may be applied to arrays of other molecular machines.

Planned Impact

This research will make a direct impact in understanding mechanisms responsible for the formation and function of cilia, influencing understanding of motor protein action, protein trafficking, the tubulin code, and organelle biogenesis, as well as ciliary functions required for numerous essential cellular and developmental processes. It will produce a postdoctoral trainee equipped with sought-after skills in challenging eukaryotic multi-protein complex production, nanotechnology and advanced fluorescence microscopy, as well as professional experience that is valuable across different economic sectors. It will foster an international collaboration that will enrich UK science. It will develop nanotechnology tools for discovery-based research, which could also aid similar technologies being used to advance drug delivery and manufacturing. Defects in intraflagellar transport are associated with vision impairment, craniofacial abnormalities, skeletal abnormalities, cystic kidneys, extra or partially fused fingers and toes, sterility, childhood obesity and developmental delay among other conditions, thus severely affecting the quality of life for sufferers and in many cases proving fatal. This research is focussed on the fundamental mechanisms of cilia assembly and function rather than characterisation of disease states, but it may help patients and their families gain a better understanding of cilia and the origin of ciliopathies. Drugs acting on cytoskeletal-motor systems involved in cell division and cardiac muscle contraction are in development for treatment of cancer and heart failure respectively, and improved understanding of intraflagellar transport may contribute to new avenues for therapeutic intervention in cilia in the long term.

Publications

10 25 50
publication icon
Webb S (2020) Intraflagellar transport trains and motors: Insights from structure. in Seminars in cell & developmental biology

publication icon
Vuolo L (2020) Cytoplasmic dynein-2 at a glance. in Journal of cell science

publication icon
Vig A (2020) DYNC2H1 hypomorphic or retina-predominant variants cause nonsyndromic retinal degeneration. in Genetics in medicine : official journal of the American College of Medical Genetics

publication icon
Toropova K (2019) Structure of the dynein-2 complex and its assembly with intraflagellar transport trains. in Nature structural & molecular biology

publication icon
Roberts A (2018) Emerging mechanisms of dynein transport in the cytoplasm versus the cilium in Biochemical Society Transactions

 
Description Cilia are antenna-like organelles found on the surface of almost every cell type in the body. They are critical for human physiology, as they they mediate detection of key stimuli in the environment (including light, smell, and morphogens) and power cell locomotion (for example the swimming of sperm). Cilia dysfunction causes severe human disorders ('ciliopathies'). A major cause of ciliopathies is defects in cilia assembly; a process that is also of fundamental interest. Cilia assembly involves a dedicated transport system that moves cargoes and signaling molecules to and from the site of assembly, at the cilia tip. Transport to the tip is driven by a kinesin motor, Kif3, and return transport is powered by the dynein-2 motor. This award generated the following discoveries and achievements:
- We discovered that dynein-2's two motor domains stack against one another and inhibit each other's activity in a 'cross-legged' conformation. This suggested a model in which inhibited dynein-2 is carried to the tip of the cilium by Kif3.
- Tools for linking together dynein-2 and Kif3 in multi-motor assemblies, using DNA origami. We used these tools to show that the inhibited form of dynein-2 can be efficiently transported by kinesin.
- Methods for purification the complete dynein-2 complex, in collaboration with Dr Andrew Carter's group at the MRC-LMB. These methods enabled us to determine the molecular structure of dynein-2.
- A collaboration with a group of clinical researchers, led by Dr. Elise Heon, which revealed that mutations in dynein-2 (which we demonstrated to impair motor activity) cause retinal degeneration.
Exploitation Route The findings and tools generated by this award have catalysed new experiments in the field, including cell biology experiments on dynein-2 regulation that would not have been possible without knowledge of its molecular structure and inhibition mechanism. Such experiments are being carried out by research groups worldwide, including our own. The finding that dynein-2 mutations cause retinal degeneration should improve genetic testing for this condition, for which the yield from gene panel screening is currently only around 66%.
Sectors Education,Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of disorders typically associated with photoreceptor degeneration. Next-generation sequencing of IRD gene panels is now commonly used for clinical genetic testing but the current yield is only around 66%. In collaboration with clinical groups, work from this grant contributed to the discovery that mutations affecting dynein-2 motor activity or expression in the eye are associated with retinal degeneration. This knowledge will improve the success rate of clinical genetic tests for retina degeneration, and reduce the need for expensive follow up tests - thus improving the efficiency of the health service. It also has the potential to improve the quality of life for individuals with retinal degeneration, by stimulating the development gene editing therapies that restore dynein-2 activity in the eye.
First Year Of Impact 2020
Sector Education,Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Societal,Economic

 
Description Dynein-2: Building and maintaining a functional primary cilium
Amount £252,065 (GBP)
Funding ID BB/S007202/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 02/2019 
End 01/2023
 
Description EMBO Young Investigator Award
Amount € 15,000 (EUR)
Organisation European Molecular Biology Organisation 
Sector Charity/Non Profit
Country Germany
Start 01/2019 
End 12/2021
 
Description Four-Year PhD Studentship in Basic Science
Amount £0 (GBP)
Funding ID 214998/Z/18/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2018 
End 09/2021
 
Description Multi-scale mechanisms of microtubule-based transport within cilia and flagella
Amount £1,729,179 (GBP)
Funding ID 217186/Z/19/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2019 
End 11/2024
 
Title Purification and structure of dynein-2 complex 
Description Recombinant expression system and cryo-EM structures of the human dynein-2 complex (collaboration with Dr. Andrew Carter's group). 
Type Of Material Technology assay or reagent 
Year Produced 2019 
Provided To Others? Yes  
Impact Publication in Nature Structural & Molecular Biology, which received research highlights in Science and NSMB, was rated as exceptional in F1000, and attracted an Altmetric score of 144 (98th percentile). A video made in conjunction with the paper has been viewed more than 10,000 times. 
 
Title Structures of the dynein-2 complex 
Description We made the following datasets available via the Electron Microscopy Databank (EMDB) and Protein Data Bank (PDB): - Cryo-EM map of the dynein-2 complex; tail domain (EMDB-4918) - Cryo-EM map of the dynein-2 complex; motor domains (EMDB-4917) - Atomic coordinates of the dynein-2 complex; motor domains (PDB-6rla) - Atomic coordinates of the dynein-2 complex; tail domain (PDB-6rlb) - Atomic coordinates of the dynein-2 complex; IFT-train bound model (PDB-6sc2) 
Type Of Material Database/Collection of data 
Year Produced 2019 
Provided To Others? Yes  
Impact These structural data have enabled us and others to interpret experiments on the dynein-2 motor protein at the level of amino acids. For example, in collaboration with Dr. Elise Heon, we were able to map the location dynein-2 mutations associated with retinal degeneration (doi.org/10.1038/s41436-020-0915-1). 
URL https://pdbj.org/emnavi/esearch.php?kw=dynein-2%20toropova
 
Description Collaboration with Dr. Elise Heon 
Organisation The Hospital for Sick Children (SickKids)
Country Canada 
Sector Hospitals 
PI Contribution Analysis of impact of patient mutations on dynein-2 motility.
Collaborator Contribution Identification of pathogenic dynein-2 mutations.
Impact Co-authored manuscript submitted for publication.
Start Year 2018
 
Description Collaboration with Drs. Dagan Jenkins and Hannah Mitchison 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Reagents for CRISPR/Cas9 genome editing of cell lines.
Collaborator Contribution Expertise in CRISPR/Cas9 genome editing.
Impact Drs. Dagan Jenkins and Hannah Mitchison collaborators on Wellcome Trust Senior Research Fellowship 217186/Z/19/Z.
Start Year 2018
 
Description Collaboration with Prof. David Stephens 
Organisation University of Bristol
Country United Kingdom 
Sector Academic/University 
PI Contribution Analysis of dynein-2 structure and dynamics.
Collaborator Contribution Analysis of dynein-2 proteomics and localisation.
Impact Award of BBSRC grant as co-applicants
Start Year 2017
 
Description A Day in the Life of... Video and Blog Post 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact In collaboration with Birkbeck Media Office, I made a "A Day in the Life of..." video and blog post. These features aimed to communicate to the general public the type of research we do, what a typical day might involve (including filming of experiments in action), and the reasons why I find science to be such a fulfilling and worthwhile career. As of 6 March 2017, the video has been viewed 1,557 times on YouTube. It has led to new interactions - for example, as a result of the video, a 6th form student emailed to express interest in and ask a question about our research, resulting in her visiting the laboratory for a placement.
Year(s) Of Engagement Activity 2017
URL https://www.youtube.com/watch?v=CRC8Z2bXTrM